Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modelling the Impact of Prevention and Treatment Interventions on HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs in Kenya

Jack Stone, Hannah Fraser, Josephine G Walker, Nyashadzaishe Mafirakureva, Bernard Mundia, Charles Cleland, Bartilol Kigen, Helgar Musyoki, Wanjiru Waruiru, Allan Ragi, Parinita Bhattacharjee, Nok Chhun, John Lizcano, Matthew J Akiyama, Peter Cherutich, Ann Kurth, Niklas Luhmann, Peter Vickerman
doi: https://doi.org/10.1101/2021.02.02.21251008
Jack Stone
1University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jack.stone@bristol.ac.uk
Hannah Fraser
1University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josephine G Walker
1University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nyashadzaishe Mafirakureva
1University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Mundia
2Kenya AIDS NGO Consortium, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Cleland
3New York University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bartilol Kigen
4Ministry of Health, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helgar Musyoki
4Ministry of Health, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanjiru Waruiru
5University of California - San Francisco, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan Ragi
2Kenya AIDS NGO Consortium, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parinita Bhattacharjee
6University of Manitoba, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nok Chhun
7Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Lizcano
7Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J Akiyama
8Albert Einstein College of Medicine, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Cherutich
4Ministry of Health, Kenya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Kurth
7Yale University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niklas Luhmann
9Médecins du Monde, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Vickerman
1University of Bristol, United Kingdom
10NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background People who inject drugs (PWID) in Kenya have a high prevalence of HIV (14-26%) and HCV (11-36%). Needle and syringe programmes (NSP) and antiretroviral therapy (ART) have high coverage among PWID, while HCV treatment and opioid substitution therapy (OST) access is low.

Methods A dynamic model of HIV (sexual and injecting-related) and HCV (injecting-related) transmission among PWID was calibrated using Bayesian methods to data from Nairobi and the Coastal region. We projected the impact of existing coverage levels of interventions (ART: 64-66%; OST: 4-7%; NSP: 54-56%) in each setting, and the impact over 2020-2030 of increasing the coverage of OST (50%) and NSP (75%; ‘full HR’), ART (UNAIDS 90-90-90 target), HCV treatment (1000 over 5 years), and reducing HIV sexual risk by 75%. We estimated HCV treatment levels needed to reduce HCV incidence by 90% with or without full HR.

Findings Since 2013, HR has averted 15.1-20.6% (range in medians across settings) of HIV infections and 29.0-31.6% of HCV infections across Nairobi and the Coastal region, with most impact being due to NSP. Conversely, ART has only averted <5% of HIV infections since 2004 because of sub-optimal viral suppression (28-48%). Going forward, Full HR and ART could reduce HIV incidence by 58.2-62.0% and HCV incidence by 62.6-81.6% by 2030 across these settings. If sexual risk is also reduced, HIV incidence would reduce by 77.1-81.4%. Alongside full HR, treating 896 PWID over 2020-2025 could reduce HCV incidence by 90% by 2030.

Interpretation Existing interventions have had moderate impact on HIV and HCV transmission in Kenya, but may have substantial impact if scaled-up. However, to achieve HIV and HCV elimination, reductions in sexual risk are needed and a scale-up in HCV treatment.

Funding Global Fund, MDM

Competing Interest Statement

HF has received an honorarium from MSD unrelated to this research. PV and JGW have received unrestricted research funding from Gilead unrelated to this work. All other authors have no disclosures.

Funding Statement

This study was funded by the Global Fund East Africa Harm Reduction Project and Medicins du Monde. JS, PV, and HF acknowledge support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation and from NIDA (R01AI147490). MJA acknowledges support from NIDA (R00DA043011). Funding for study data provided from AK and PC was from NIDA 5R01DA032080.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

None needed. This is a modelling study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Model code will be shared with researchers who provide a methodologically sound proposal approved by Dr Jack Stone and Professor Peter Vickerman. Proposals should be directed to jack.stone{at}bristol.ac.uk and Peter.vickerman{at}bristol.ac.uk; requesters will need to sign a data access agreement.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted February 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modelling the Impact of Prevention and Treatment Interventions on HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs in Kenya
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modelling the Impact of Prevention and Treatment Interventions on HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs in Kenya
Jack Stone, Hannah Fraser, Josephine G Walker, Nyashadzaishe Mafirakureva, Bernard Mundia, Charles Cleland, Bartilol Kigen, Helgar Musyoki, Wanjiru Waruiru, Allan Ragi, Parinita Bhattacharjee, Nok Chhun, John Lizcano, Matthew J Akiyama, Peter Cherutich, Ann Kurth, Niklas Luhmann, Peter Vickerman
medRxiv 2021.02.02.21251008; doi: https://doi.org/10.1101/2021.02.02.21251008
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Modelling the Impact of Prevention and Treatment Interventions on HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs in Kenya
Jack Stone, Hannah Fraser, Josephine G Walker, Nyashadzaishe Mafirakureva, Bernard Mundia, Charles Cleland, Bartilol Kigen, Helgar Musyoki, Wanjiru Waruiru, Allan Ragi, Parinita Bhattacharjee, Nok Chhun, John Lizcano, Matthew J Akiyama, Peter Cherutich, Ann Kurth, Niklas Luhmann, Peter Vickerman
medRxiv 2021.02.02.21251008; doi: https://doi.org/10.1101/2021.02.02.21251008

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5872)
  • Intensive Care and Critical Care Medicine (362)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (233)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2012)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)